Advertisement
ASTH vs EXETF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and EXETF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 1 FA rating(s) are green whileEXETF’s FA Score has 4 green FA rating(s).
- ASTH’s FA Score: 1 green, 4 red.
- EXETF’s FA Score: 4 green, 1 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 6 TA indicator(s) are bullish while EXETF’s TA Score has 4 bullish TA indicator(s).
- ASTH’s TA Score: 6 bullish, 5 bearish.
- EXETF’s TA Score: 4 bullish, 3 bearish.
Price Growth
ASTH (@Hospital/Nursing Management) experienced а -10.29% price change this week, while EXETF (@Hospital/Nursing Management) price change was +23.30% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.22%. For the same industry, the average monthly price growth was -6.66%, and the average quarterly price growth was +2.60%.
Reported Earning Dates
ASTH is expected to report earnings on Feb 19, 2026.
EXETF is expected to report earnings on Feb 26, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-2.22% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ASTH | EXETF | ASTH / EXETF | |
| Capitalization | 1.07B | 1.2B | 89% |
| EBITDA | 112M | 164M | 68% |
| Gain YTD | -32.287 | 97.249 | -33% |
| P/E Ratio | 112.37 | 18.97 | 592% |
| Revenue | 2.42B | 1.51B | 160% |
| Total Cash | 342M | 72.6M | 471% |
| Total Debt | 448M | 284M | 158% |
ASTH | EXETF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 96 | 7 | |
SMR RATING 1..100 | 84 | 17 | |
PRICE GROWTH RATING 1..100 | 91 | 37 | |
P/E GROWTH RATING 1..100 | 4 | 16 | |
SEASONALITY SCORE 1..100 | 90 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EXETF's Valuation (10) in the null industry is significantly better than the same rating for ASTH (83). This means that EXETF’s stock grew significantly faster than ASTH’s over the last 12 months.
EXETF's Profit vs Risk Rating (7) in the null industry is significantly better than the same rating for ASTH (96). This means that EXETF’s stock grew significantly faster than ASTH’s over the last 12 months.
EXETF's SMR Rating (17) in the null industry is significantly better than the same rating for ASTH (84). This means that EXETF’s stock grew significantly faster than ASTH’s over the last 12 months.
EXETF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for ASTH (91). This means that EXETF’s stock grew somewhat faster than ASTH’s over the last 12 months.
ASTH's P/E Growth Rating (4) in the null industry is in the same range as EXETF (16). This means that ASTH’s stock grew similarly to EXETF’s over the last 12 months.
| ASTH | EXETF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 73% | 2 days ago 59% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 56% |
| TrendWeek ODDS (%) | 2 days ago 75% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 58% |
| Advances ODDS (%) | 14 days ago 78% | 2 days ago 60% |
| Declines ODDS (%) | 3 days ago 73% | N/A |
| BollingerBands ODDS (%) | 2 days ago 81% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 72% | 2 days ago 55% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DRGVX | 49.99 | N/A | N/A |
| BNY Mellon Dynamic Value Fund I | |||
| JDEZX | 15.91 | N/A | N/A |
| PGIM Jennison Global Equity Income Z | |||
| MECZX | 53.80 | N/A | N/A |
| AMG GW&K International Small Cap Z | |||
| BRXBX | 16.71 | -0.16 | -0.95% |
| MFS Blended Research Intl Eq B | |||
| NWXUX | 11.59 | -0.13 | -1.11% |
| Nationwide International Sm Cp R6 | |||
ASTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.
| Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
|---|---|---|---|---|
| ASTH | 100% | +1.52% | ||
| ACHC - ASTH | 51% Loosely correlated | -4.09% | ||
| DCGO - ASTH | 38% Loosely correlated | -3.40% | ||
| UHS - ASTH | 30% Poorly correlated | +1.03% | ||
| ENSG - ASTH | 30% Poorly correlated | +0.50% | ||
| PNTG - ASTH | 29% Poorly correlated | +2.72% | ||
More | ||||
EXETF and
Correlation & Price change
A.I.dvisor tells us that EXETF and FSNUF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXETF and FSNUF's prices will move in lockstep.
| Ticker / NAME | Correlation To EXETF | 1D Price Change % | ||
|---|---|---|---|---|
| EXETF | 100% | +1.85% | ||
| FSNUF - EXETF | 28% Poorly correlated | N/A | ||
| AIRS - EXETF | 27% Poorly correlated | -1.92% | ||
| INNV - EXETF | 23% Poorly correlated | +12.47% | ||
| ASTH - EXETF | 22% Poorly correlated | +1.52% | ||
| THC - EXETF | 22% Poorly correlated | +0.31% | ||
More | ||||